Management of bleeding with uremia and liver disease

    Research output: Contribution to journalArticle

    11 Citations (Scopus)

    Abstract

    Bleeding can complicate the clinical course of both liver disease and uremia. The pathogenesis of bleeding in both syndromes is complex. A variety of options are available for treatment of uremic bleeding including desmopressin, erythropoietin, and estrogens. Bleeding complications of liver disease reflect the importance of this organ for the production of both coagulation factors and thrombopoietin. Careful assessment of both the patient's clinical situation and laboratory findings is important for tailoring therapy of the bleeding patient. (C) 1999 Lippincott Williams and Wilkins, Inc.

    Original languageEnglish (US)
    Pages (from-to)329-333
    Number of pages5
    JournalCurrent Opinion in Hematology
    Volume6
    Issue number5
    DOIs
    StatePublished - 1999

    Fingerprint

    Uremia
    Liver Diseases
    Hemorrhage
    Thrombopoietin
    Deamino Arginine Vasopressin
    Blood Coagulation Factors
    Erythropoietin
    Estrogens
    Therapeutics

    ASJC Scopus subject areas

    • Hematology

    Cite this

    Management of bleeding with uremia and liver disease. / Deloughery, Thomas.

    In: Current Opinion in Hematology, Vol. 6, No. 5, 1999, p. 329-333.

    Research output: Contribution to journalArticle

    @article{f1f6f552e2054cbb820c090086e65c95,
    title = "Management of bleeding with uremia and liver disease",
    abstract = "Bleeding can complicate the clinical course of both liver disease and uremia. The pathogenesis of bleeding in both syndromes is complex. A variety of options are available for treatment of uremic bleeding including desmopressin, erythropoietin, and estrogens. Bleeding complications of liver disease reflect the importance of this organ for the production of both coagulation factors and thrombopoietin. Careful assessment of both the patient's clinical situation and laboratory findings is important for tailoring therapy of the bleeding patient. (C) 1999 Lippincott Williams and Wilkins, Inc.",
    author = "Thomas Deloughery",
    year = "1999",
    doi = "10.1097/00062752-199909000-00010",
    language = "English (US)",
    volume = "6",
    pages = "329--333",
    journal = "Current Opinion in Hematology",
    issn = "1065-6251",
    publisher = "Lippincott Williams and Wilkins",
    number = "5",

    }

    TY - JOUR

    T1 - Management of bleeding with uremia and liver disease

    AU - Deloughery, Thomas

    PY - 1999

    Y1 - 1999

    N2 - Bleeding can complicate the clinical course of both liver disease and uremia. The pathogenesis of bleeding in both syndromes is complex. A variety of options are available for treatment of uremic bleeding including desmopressin, erythropoietin, and estrogens. Bleeding complications of liver disease reflect the importance of this organ for the production of both coagulation factors and thrombopoietin. Careful assessment of both the patient's clinical situation and laboratory findings is important for tailoring therapy of the bleeding patient. (C) 1999 Lippincott Williams and Wilkins, Inc.

    AB - Bleeding can complicate the clinical course of both liver disease and uremia. The pathogenesis of bleeding in both syndromes is complex. A variety of options are available for treatment of uremic bleeding including desmopressin, erythropoietin, and estrogens. Bleeding complications of liver disease reflect the importance of this organ for the production of both coagulation factors and thrombopoietin. Careful assessment of both the patient's clinical situation and laboratory findings is important for tailoring therapy of the bleeding patient. (C) 1999 Lippincott Williams and Wilkins, Inc.

    UR - http://www.scopus.com/inward/record.url?scp=0033302948&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0033302948&partnerID=8YFLogxK

    U2 - 10.1097/00062752-199909000-00010

    DO - 10.1097/00062752-199909000-00010

    M3 - Article

    C2 - 10468149

    AN - SCOPUS:0033302948

    VL - 6

    SP - 329

    EP - 333

    JO - Current Opinion in Hematology

    JF - Current Opinion in Hematology

    SN - 1065-6251

    IS - 5

    ER -